Prospective Study of Hormone Levels After Bariatric Surgery
2 other identifiers
observational
236
1 country
1
Brief Summary
This project will study the effects of surgery for obesity on bone metabolism and hormones that regulate appetite.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2003
CompletedFirst Submitted
Initial submission to the registry
February 28, 2008
CompletedFirst Posted
Study publicly available on registry
March 3, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 4, 2018
CompletedSeptember 19, 2019
September 1, 2019
15.6 years
February 28, 2008
September 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in body weight
linear mixed model analysis will be used to study change over time and between surgery
5 years
Study Arms (1)
Surgery
Obese adult men and women who are undergoing bariatric surgery (gastric bypass or gastric banding).
Interventions
Eligibility Criteria
Subjects will be recruited from the outpatient obesity and surgical clinics at Columbia-Presbyterian Medical Center after they have chosen to undergo a surgical procedure.
You may qualify if:
- Adult male or female \> 18 years of age
- Scheduled to undergo bariatric surgery
You may not qualify if:
- Vitamin D deficiency
- Primary hyperparathyroidism
- Treatment with lithium or thiazide diuretics which may alter PTH levels
- Osteomalacia
- Untreated hyperthyroidism, liver disease, Cushing's syndrome, rheumatoid arthritis, myeloma or Paget's disease
- Impaired renal function (serum creatinine \>2.0mg/dl) or history of renal osteodystrophy
- Use of any anti-obesity medications for over 2 weeks 90 days prior to study
- Participation in any research study 90 days prior to study
- Any malabsorption syndromes such as celiac sprue
- Previous bariatric surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University Medical Center
New York, New York, 10032, United States
Biospecimen
blood samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Judith Korner, MD,PhD
Columbia University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
February 28, 2008
First Posted
March 3, 2008
Study Start
March 17, 2003
Primary Completion
November 4, 2018
Study Completion
November 4, 2018
Last Updated
September 19, 2019
Record last verified: 2019-09